Literature DB >> 16854961

Parametric mapping of the hepatic perfusion index with gadolinium-enhanced volumetric MRI.

M J White1, R L O'Gorman, E M Charles-Edwards, P A Kane, J B Karani, M O Leach, J J Totman.   

Abstract

The purpose of this study was to adapt the hepatic perfusion index (HPI) methodology previously developed for MRI to derive 3D parametric maps of HPI, and to investigate apparent differences in HPI maps between a group of colorectal cancer patients and controls. To achieve this, a new and simpler approach to HPI calculation which does not require measurements from the aorta or portal vein is introduced, and assessed with large liver regions of interest (ROIs) in patients and controls. Several example HPI maps showing localized variation are then presented. The subject group consisted of 12 patients with known colorectal metastases, and 13 control subjects referred for routine contrast-enhanced spine imaging with no history of neoplastic disease. HPI was evaluated from serial T1 volume acquisitions acquired over the course of a Gd-DTPA bolus injection. Regions of abnormal perfusion were visible on the HPI maps derived for the patient group, manifested as areas of locally increased HPI extending around the visible margins of known metastases evident on the conventional contrast-enhanced images. This method for MR voxel-based parametric mapping of HPI has the potential to demonstrate regional variations in perfusion at the segmental and subsegmental level.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16854961     DOI: 10.1259/bjr/36793733

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  6 in total

1.  Changes in hepatic perfusion assessed by dynamic contrast enhanced MRI, associated with morphologic evaluation, in patients with liver metastases from colorectal cancer treated with first-line chemotherapy.

Authors:  Marco Tampellini; Dario Gned; Chiara Baratelli; Maria Pia Brizzi; Azzurra Ottone; Irene Alabiso; Chiara Bertaggia; Massimo Di Maio; Giorgio Vittorio Scagliotti; Andrea Veltri
Journal:  Radiol Med       Date:  2016-09-06       Impact factor: 3.469

2.  The evaluation of haemodynamics in cirrhotic patients with spectral CT.

Authors:  L-Q Zhao; W He; B Yan; H-Y Wang; J Wang
Journal:  Br J Radiol       Date:  2013-08       Impact factor: 3.039

3.  Whole-liver CT texture analysis in colorectal cancer: Does the presence of liver metastases affect the texture of the remaining liver?

Authors:  Sheng-Xiang Rao; Doenja Mj Lambregts; Roald S Schnerr; Wenzel van Ommen; Thiemo Ja van Nijnatten; Milou H Martens; Luc A Heijnen; Walter H Backes; Cornelis Verhoef; Meng-Su Zeng; Geerard L Beets; Regina Gh Beets-Tan
Journal:  United European Gastroenterol J       Date:  2014-12       Impact factor: 4.623

4.  Quantitative mapping of hepatic perfusion index using MR imaging: a potential reproducible tool for assessing tumour response to treatment with the antiangiogenic compound BIBF 1120, a potent triple angiokinase inhibitor.

Authors:  Keiko Miyazaki; David J Collins; Simon Walker-Samuel; Jane N Taylor; Anwar R Padhani; Martin O Leach; Dow-Mu Koh
Journal:  Eur Radiol       Date:  2008-03-20       Impact factor: 5.315

5.  Tumor attenuation and quantitative analysis of perfusion parameters derived from tri-phasic CT scans in hepatocellular carcinoma: Relationship with histological grade.

Authors:  Guodong Pang; Chunchun Shao; Yao Lv; Fang Zhao
Journal:  Medicine (Baltimore)       Date:  2021-04-23       Impact factor: 1.817

6.  Detection of recurrent hepatocellular carcinoma in cirrhotic liver after transcatheter arterial chemoembolization: value of quantitative color mapping of the arterial enhancement fraction of the liver.

Authors:  Dong Ho Lee; Jeong Min Lee; Ernst Klotz; Soo Jin Kim; Kyung Won Kim; Joon Koo Han; Byung Ihn Choi
Journal:  Korean J Radiol       Date:  2012-12-28       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.